Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

UARK 2014-21: Phase II Trial of Oncolytic Virotherapy by Systemic Administration of Edmonston Strain of Measles Virus, Genetically Engineered to Express NIS with Cyclophosphamide in Patients with Recurrent or Refractory Multiple Myeloma


Collapse Overview 
Collapse sponsor award id
EdmonstonStrainofMeaslesVirus


Collapse Biography 

Collapse Time 
Collapse start date
2015-04-08